Achieving asthma control

Current Medical Research and Opinion, Supplement

Volumn 21, Issue 4, 2005, Pages

  Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Asthma control; Asthma management; Inhalation devices; Non compliance; Patient choice

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHEMOKINE RECEPTOR ANTAGONIST; CORTICOSTEROID; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; OXYGENASE INHIBITOR; PHOSPHODIESTERASE IV INHIBITOR;

AEROSOL; AIRWAY; ASTHMA; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; HEALTH CARE COST; HUMAN; METERED DOSE INHALER; PATIENT COMPLIANCE; PATIENT EDUCATION; POWDER INHALER; PRACTICE GUIDELINE; QUALITY OF LIFE;

ANTI-ASTHMATIC AGENTS; ASTHMA; HUMANS; PATIENT COMPLIANCE; PRACTICE GUIDELINES;

EID: 25444433139     PISSN: 01419951     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079905X61730     Document Type: Conference Paper

References (17)

1. National Institute of Health, National Heart, Lung and Blood Institute. Global initiative for asthma - global strategy for asthma management and prevention. NHLI/WHO workshop report. NIH Publication Number 02-3659. Updated October 2004
2. Basagana X, Sunyer J, Zock J, et al. Incidence of asthma and its determinants among adults in Spain. Am J Respir Crit Care Med 2001;164:1133-7
3. Lundback B, Ronmark E, Jonsson E, Larsson K, Sandström T. Incidence of physician-diagnosed asthma in adults - a real incidence or a result of increased awareness? Respir Med 2001;95:685-92
4. Sole D, Yamada E, Vana A, Costa-Carvalho B, Naspitz C. Prevalence of asthma and related symptoms in school-aged children in Sao Paulo, Brazil. International Study of Asthma and Allergies in Children (ISAAC). J Asthma 1999;36:205-12
5. Adams R, Wilson D, Appleton S, et al. Under-diagnosed asthma in South Australia. Thorax 2003;58:846-50
6. British Thoracic Society; Scottish Intercollegiate Guidelines Network. British Guideline on the management of asthma. Thorax 2003;58 (Suppl 1):i1-94
7. Rabe K, Vermeire P, Soriano J, Maier W. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000;16:802-7
8. Gruffydd-Jones K. Measuring pulmonary function in practice. Practitioner 2002;246:445-9
9. Chalmers G, Macleod K, Little S, Thomson L, McSharry C, Thomson N. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002;57:226-30
10. Chaudhuri R, Livingston E, McMahon A, Thomson L, Borland W, Thomson N. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003;168:1308-11
11. de Benedictis F, Delvaggio D. Use of inhaler devices in pediatric asthma. Paediatr Drugs 2003;5:629-38
12. Hesselink A, Penninx B, Wijnhoven H, Kriegsman D, Van Eijk J. Determinants of an incorrect inhalation technique in patients with asthma or COPD. Scan J Prim Health Care 2001;19:255-60
13. Crompton G. Problems patients have using pressurized aerosol inhalers. Eur Respir Dis 1982;(Suppl 119):101-4
14. Lenney J, Innes J, Crompton G. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI. Respir Med 2000;94:496-500
15. Crompton G, Duncan J. Clinical assessment of a new breath-activated inhaler. Practitioner 1989;233:268-9
16. Hamid Q, Song Y, Kotsimbos T, et al. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997;100:44-51
17. Moeller M, Pritsche D, Rivera D, Libertus H. Improvement of asthma therapy by a novel budesonide multidose dry powder inhaler. Arzneimittelforschung 2003;53:562-7